You just read:

New Application of Lenvatinib in Combination with Everolimus for Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC) Submitted to the European Medicines Agency (EMA) by Eisai

News provided by

Eisai

12 Jan, 2016, 00:01 GMT